Cell Line Derived Multi-Gene Predictor of Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer: A Validation Study on US Oncology 02-103 Clinical Trial
© Shen et al.; licensee BioMed Central Ltd. 2012
Received: 19 March 2012
Accepted: 12 November 2012
Published: 16 November 2012
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting email@example.com.
|19 Mar 2012||Submitted||Original manuscript|
|28 May 2012||Reviewed||Reviewer Report - Maud Starmans|
|25 Jun 2012||Reviewed||Reviewer Report - Jorge Reis-Filho|
|15 Sep 2012||Author responded||Author comments - Nan Song|
|Resubmission - Version 2|
|15 Sep 2012||Submitted||Manuscript version 2|
|27 Sep 2012||Reviewed||Reviewer Report - Jorge Reis-Filho|
|2 Oct 2012||Reviewed||Reviewer Report - Maud Starmans|
|19 Oct 2012||Author responded||Author comments - Nan Song|
|Resubmission - Version 3|
|19 Oct 2012||Submitted||Manuscript version 3|
|12 Nov 2012||Editorially accepted|
|16 Nov 2012||Article published||10.1186/1755-8794-5-51|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting firstname.lastname@example.org. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.